Photo of Scott Xiao

Biotechnology & medicine

Scott Xiao

Digital therapy aimed at retraining the brain to process images.

Year Honored



Hails From

Amblyopia, the leading cause of vision loss in children, is usually treated by having patients wear a patch over the stronger eye to stimulate the weaker one. Despite how prevalent the condition is, affecting 3% of children, it can be hard to get kids to comply with wearing the eye patch, partly because of social stigma. Scott Xiao, 24, has won FDA approval for an alternative: a digital therapy aimed at retraining the brain to process images from both eyes properly. It involves presenting popular TV shows slightly differently to each eye via a virtual-reality headsetmaking it the first FDA-approved VR therapeutic for any condition.